Steps: New drug reviews: Elagolix, estradiol, and norethindrone kit (oriahnn) for the management of heavy menstrual bleeding associated with fibroids

Simple item page
dc.contributor.authorAntoun, Jumana M.
dc.contributor.departmentFamily Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:42:28Z
dc.date.available2025-01-24T11:42:28Z
dc.date.issued2021
dc.identifier.eid2-s2.0-85108274769
dc.identifier.urihttp://hdl.handle.net/10938/30023
dc.language.isoen
dc.publisherAmerican Academy of Family Physicians
dc.relation.ispartofAmerican Family Physician
dc.sourceScopus
dc.subjectElagolix plus estradiol plus norethisterone acetate
dc.subjectHemoglobin
dc.subjectBlood volume
dc.subjectBone density
dc.subjectDisease association
dc.subjectDrug cost
dc.subjectDrug efficacy
dc.subjectDrug safety
dc.subjectDrug tolerability
dc.subjectHuman
dc.subjectMenorrhagia
dc.subjectMetrorrhagia
dc.subjectOsteolysis
dc.subjectPrice
dc.subjectReview
dc.subjectUterus myoma
dc.titleSteps: New drug reviews: Elagolix, estradiol, and norethindrone kit (oriahnn) for the management of heavy menstrual bleeding associated with fibroids
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2021-2609.pdf
Size:
89.4 KB
Format:
Adobe Portable Document Format
Download

Collections

Family Medicine